1. Home
  2. TPST vs CPSH Comparison

TPST vs CPSH Comparison

Compare TPST & CPSH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TPST
  • CPSH
  • Stock Information
  • Founded
  • TPST 2011
  • CPSH 1984
  • Country
  • TPST United States
  • CPSH United States
  • Employees
  • TPST N/A
  • CPSH N/A
  • Industry
  • TPST Biotechnology: Pharmaceutical Preparations
  • CPSH Building Materials
  • Sector
  • TPST Health Care
  • CPSH Consumer Discretionary
  • Exchange
  • TPST Nasdaq
  • CPSH Nasdaq
  • Market Cap
  • TPST 33.0M
  • CPSH 36.6M
  • IPO Year
  • TPST N/A
  • CPSH 1987
  • Fundamental
  • Price
  • TPST $7.76
  • CPSH $2.53
  • Analyst Decision
  • TPST Hold
  • CPSH
  • Analyst Count
  • TPST 3
  • CPSH 0
  • Target Price
  • TPST $30.00
  • CPSH N/A
  • AVG Volume (30 Days)
  • TPST 80.4K
  • CPSH 63.0K
  • Earning Date
  • TPST 08-07-2025
  • CPSH 08-04-2025
  • Dividend Yield
  • TPST N/A
  • CPSH N/A
  • EPS Growth
  • TPST N/A
  • CPSH N/A
  • EPS
  • TPST N/A
  • CPSH N/A
  • Revenue
  • TPST N/A
  • CPSH $22,716,633.00
  • Revenue This Year
  • TPST N/A
  • CPSH N/A
  • Revenue Next Year
  • TPST N/A
  • CPSH N/A
  • P/E Ratio
  • TPST N/A
  • CPSH N/A
  • Revenue Growth
  • TPST N/A
  • CPSH N/A
  • 52 Week Low
  • TPST $5.35
  • CPSH $1.27
  • 52 Week High
  • TPST $28.34
  • CPSH $3.18
  • Technical
  • Relative Strength Index (RSI)
  • TPST 63.65
  • CPSH 46.47
  • Support Level
  • TPST $6.11
  • CPSH $2.45
  • Resistance Level
  • TPST $6.49
  • CPSH $2.68
  • Average True Range (ATR)
  • TPST 0.35
  • CPSH 0.21
  • MACD
  • TPST 0.03
  • CPSH -0.02
  • Stochastic Oscillator
  • TPST 100.00
  • CPSH 56.58

About TPST Tempest Therapeutics Inc.

Tempest Therapeutics Inc is a late-stage develpment biotechnology company developing small molecule therapeutics to treat cancer through mechanisms that directly kill tumor cells and activate tumor-specific immunity. Its clinical-stage therapeutic product candidates are TPST-1120 and TPST-1495 which are clinical-stage molecules designed to inhibit their respective targets.

About CPSH CPS Technologies Corp.

CPS Technologies Corp provides material solutions to the transportation, automotive, energy, computing/Internet, telecommunications, aerospace, defense, and oil and gas end markets. Its primary material solution is metal matrix composites (MMCs), which are a class of materials consisting of a combination of metal and ceramic. The company designs, manufactures and sells custom MMC components, which manages the performance and reliability of systems in the end markets. It also provides baseplates and housings used in radar, satellite and avionics applications. The company provides lids and heat spreaders used with integrated circuits in Internet switches and routers.

Share on Social Networks: